GC Wealth Management RIA’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$786K Buy
11,130
+46
+0.4% +$2.48K 0.05% 264
2026
Q1
$579K Sell
11,084
-109
-1% -$6.54K 0.02% 320
2025
Q4
$658K Sell
11,193
-6,032
-35% -$367K 0.02% 307
2025
Q3
$958K Buy
17,225
+5,692
+49% +$305K 0.03% 341
2025
Q2
$593K Buy
11,533
+284
+3% +$14.3K 0.05% 289
2025
Q1
$660K Buy
11,249
+77
+0.7% +$5.22K 0.12% 151
2024
Q4
$805K Buy
+11,172
New +$820K 0.14% 121

Other funds holding TECH

GC Wealth Management RIA's TECH Position: Q2 2026 in Review

GC Wealth Management RIA increased its Bio-Techne (TECH) stake by 0.42% in Q2 2026, buying an estimated $2.48K and bringing the position to 11,130 shares worth $786K. The position accounts for 0.05% of the portfolio, ranked #264.

GC Wealth Management RIA first reported a position in TECH in Q4 2024 and has held it in 7 quarters since. The position peaked at $958K in Q3 2025. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • GC Wealth Management RIA held 11,130 shares of Bio-Techne worth $786K as of Q2 2026.
  • GC Wealth Management RIA bought 46 Bio-Techne shares in Q2 2026, an estimated $2.48K.
  • Bio-Techne made up 0.05% of GC Wealth Management RIA's portfolio in Q2 2026, its #264 holding.
  • GC Wealth Management RIA first reported a position in Bio-Techne in Q4 2024 and has held it in 7 quarters since.
  • GC Wealth Management RIA's Bio-Techne position peaked at $958K in Q3 2025.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on GC Wealth Management RIA's 13F filing for Q2 2026, filed 16 Jul 2026.